Submitted by Anonymous (not verified) on 12 September 2025 - 15:10
Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 9, Status: Authorised